Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ABclonal
company
About
ABclonal is a biotechnology company that is a supplier of global antibody and molecular enzyme reagents.
- 251 - 500
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥1.20B
- Industries
- Biometrics,Biopharma,Biotechnology
- Founded date
- Jan 1, 2011
- Number Of Employee
- 251 - 500
- Operating Status
- Active
ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥1.20B $93M
ABclonal has raised a total of
¥1.20B $93M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2021 | Series D | ¥1.20B | 2 | — | — | Detail |
| Feb 22, 2021 | Series C | $93M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
ABclonal is funded by 4 investors.
Taikang Touzi
and Zhengxingu Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
|
|
— | Series C |
Sigma Square Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
